(Q39125659)

English

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial

scientific article published on 18 September 2014

Statements

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial (English)
Daniel Castellano
Sebastien J Hotte
Paul N Mainwaring
José M Tello Garrido
Daniel J George
Abiraterone Global EAP Investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit